Immunogenicity, Efficacy and Safety of Recombinant Herpes Zoster Vaccine in Frail Patients
N/A
Herpes zoster (HZ) is a serious health problem whose incidence and severity...
Status
Recruiting
Location
Fondazione IRCCS Policlinico San Matteo, SC Microbiologia e Virologia
Start Date
2023-05-16
Trial ID
NCT07321808
Safety and Immunogenicity of Recombinant Varicella Zoster Virus Vaccine in People With HIV Who Have a CD4 Count Less Than 300 or Greater Than or Equal to 300 and a Healthy Control Population
PHASE1
Background:
Shingles is a painful, blistering rash caused by the same viru...
A Study on the Immune Response and Safety of the Shingles Vaccine and the Influenza Vaccine When Either is Given to Healthy Adults at the Same Time or Following a COVID-19 Booster Vaccine
PHASE3
The aim of this study was to evaluate the immune response and safety of bot...